
Rockwell Medical RMTI
$ 0.81
-0.32%
Quarterly report 2025-Q3
added 11-12-2025
Country |
|
IPO year |
1998 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
23.3 M |
Market Cap[1] |
$ 18.9 M |
EBITDA (LTM) |
$ 1.12 M |
P/E (LTM) |
-21.75 |
P/S (LTM) |
0.24 |
EPS (LTM) |
-0.04 |
Other stocks of industry "Drug manufacturers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | ||
|
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | ||
|
Canopy Growth Corporation
CGC
|
$ 1.17 | 0.43 % | $ 126 M | Nasdaq Global Select Market | ||
|
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | ||
|
Cronos Group
CRON
|
$ 2.62 | -0.19 % | $ 1.38 B | Nasdaq Global Market | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | ||
|
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | ||
|
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | ||
|
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | ||
|
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | ||
|
Aurora Cannabis
ACB
|
$ 4.27 | 0.18 % | $ 86.3 M | NYSE | ||
|
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB | ||
|
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | ||
|
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market | ||
|
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | ||
|
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | ||
|
Emergent BioSolutions
EBS
|
$ 12.32 | 1.32 % | $ 631 M | NYSE,SPB | ||
|
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | ||
|
Avadel Pharmaceuticals plc
AVDL
|
$ 21.53 | -0.07 % | $ 2.05 B | Nasdaq Global Select Market | ||
|
OrganiGram Holdings
OGI
|
$ 1.7 | -0.29 % | $ 402 M | Nasdaq Global Select Market | ||
|
Organogenesis Holdings
ORGO
|
$ 5.18 | -0.1 % | $ 682 M | Nasdaq Capital Market | ||
|
Evolus
EOLS
|
$ 6.69 | 0.25 % | $ 415 M | Nasdaq Global Market | ||
|
Harrow Health
HROW
|
$ 50.1 | 0.16 % | $ 1.63 B | Nasdaq Global Market | ||
|
China Pharma Holdings
CPHI
|
$ 1.33 | - | $ 23.2 M | NYSE American | ||
|
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | ||
|
Sonoma Pharmaceuticals
SNOA
|
$ 3.57 | -1.3 % | $ 4.43 M | Nasdaq Capital Market | ||
|
Bausch Health Companies
BHC
|
$ 7.01 | 0.21 % | $ 2.56 B | NYSE | ||
|
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | ||
|
Cumberland Pharmaceuticals
CPIX
|
$ 3.94 | -0.51 % | $ 55.4 M | Nasdaq Global Select Market | ||
|
Pacira BioSciences
PCRX
|
$ 26.08 | 0.04 % | $ 1.21 B | Nasdaq Global Select Market,SPB | ||
|
Sundial Growers
SNDL
|
$ 1.65 | 0.02 % | $ 3.37 M | Nasdaq Global Select Market | ||
|
Veru
VERU
|
$ 2.13 | -1.84 % | $ 287 M | Nasdaq Capital Market | ||
|
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | ||
|
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | ||
|
Perrigo Company plc
PRGO
|
$ 13.91 | -0.25 % | $ 1.91 B | NYSE | ||
|
ProPhase Labs
PRPH
|
$ 0.44 | -4.02 % | $ 6.97 M | Nasdaq Capital Market | ||
|
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | ||
|
cbdMD
YCBD
|
$ 1.39 | 1.84 % | $ 5.99 M | NYSE American | ||
|
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | ||
|
Relmada Therapeutics
RLMD
|
$ 4.73 | 4.42 % | $ 142 M | Nasdaq Global Select Market,SPB | ||
|
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | ||
|
Assertio Holdings
ASRT
|
$ 8.85 | -3.8 % | $ 629 M | Nasdaq Capital Market | ||
|
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | ||
|
Solid Biosciences
SLDB
|
$ 5.71 | 0.18 % | $ 233 M | Nasdaq Global Select Market,SPB | ||
|
SCYNEXIS
SCYX
|
$ 0.62 | 2.61 % | $ 29.7 M | Nasdaq Global Select Market | ||
|
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | ||
|
Tilray
TLRY
|
$ 9.19 | 1.88 % | $ 5.68 B | Nasdaq Global Select Market | ||
|
TherapeuticsMD
TXMD
|
$ 1.68 | 2.13 % | $ 17.5 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.